Mast Cell Activation Syndrome. When your body reacts everywhere and no one says why.
Why this condition is often considered untreatable, even though there is almost always a cause behind it. What mould, heavy metals, stress, Borrelia and Long COVID may have to do with it. And how functional medicine, PNI and anthroposophic medicine can together open a path forward.
There is a moment in the consulting room when a woman puts her list on the table. Forty symptoms. Six specialists. Three antidepressants. And one sentence that appeared everywhere. All unremarkable.
She is in her mid-thirties, an architect, two children. She sits across from me with her coat on her lap, because she is constantly cold and at the same time too warm. She reacts to perfume, to wine, to cleaning products, to certain fabrics. Sometimes her skin turns red when she showers, sometimes she itches for no reason. Her belly bloats after every meal, she has migraines, palpitations, sometimes her circulation drops when she stands up. She sleeps poorly, has wild dreams, wakes in panic. Three years ago she had a severe COVID infection. Nothing has been the same since. Her joints have always been hypermobile, she did the splits as a child without warming up. Two years ago her husband discovered mould behind the cupboard in the children's room. Three old amalgam fillings were recently removed without protective measures, after which a new flare came. Allergy tests show little specific. Her family doctor has carefully suggested she consult a psychotherapist. She herself says to me. I know something is not right. I am slowly tired of having to explain this over and over.
I know this picture. Maybe you recognise yourself or someone you love. Multisystemic complaints that no single specialty can place. A diagnosis that no one makes, because it is missing from most textbooks. Or a diagnosis someone has spoken once and which has been used like a label ever since, supposed to explain everything but treating nothing.
Mast Cell Activation Syndrome, or MCAS, is exactly this picture. A young term in medicine. An old suffering in clinics. And a topic that matters to me for two reasons. First, because I see many people with it. Second, because there is almost always a story behind MCAS. A story of stress, infections, environmental toxins, connective tissue, trauma. Whoever understands that story can intervene. Whoever does not listen to it only fights symptoms.
What will happen in this text is a journey. We look at what mast cells are. We look at why your body reacts everywhere. We look at what can really stand behind it. And we look at the paths that exist. From functional medicine, from PNI, from an anthroposophically informed perspective. Not as marketing, but as an honest survey of what helps and what does not.
Section 1What mast cells really are
Imagine a small, round cell, packed with hundreds of vesicles. This cell does not sit in your blood. It sits where the world and the body meet. In the skin, in the mucous membranes of nose, lung, stomach, gut, urogenital tract. On the walls of your blood vessels. Around your nerves. These are the mast cells. They have been conserved for over five hundred million years in almost all vertebrates because they are evolutionarily essential.
Their first job is to detect intruders. They carry antennae for bacteria, viruses, fungi, parasites, toxins. As soon as they spot something suspicious, they raise the alarm. This alarm is not only histamine, as many people think. Mast cells release more than two hundred different messengers. Histamine is the most famous. But there is also tryptase, chymase, heparin, prostaglandins, leukotrienes, platelet-activating factor, cytokines like TNF and interleukin 6, and many others.
When a healthy person is stung by a bee, the mast cells do exactly what they were built for. They react locally, briefly and forcefully. Swelling and redness at the sting site, immune cells called in, then they retreat. That is defence. When a healthy person fights a parasitic infection, mast cells are part of the response that keeps the worm load in check. That too is defence.
The problem begins when the mast cell does not stop. When it no longer reacts only to real threats but to many things. To certain foods. To smells. To temperature changes. To stress. To hormonal shifts. To certain medications. To sometimes seemingly nothing at all. When this state becomes chronic and spans several organ systems, we speak of Mast Cell Activation Syndrome.
Mast cells are not your enemies. They are over-awake guards who have at some point been signalled too many threats at once, and who have not slept properly since.
Section 2When your body reacts everywhere at once
One of the biggest challenges for patients and for doctors is that MCAS does not show up in one specialty. It shows up in almost all of them. People with MCAS get an ointment from the dermatologist. From the gastroenterologist they get an acid blocker and the label irritable bowel. From the cardiologist they get a long-term ECG and the message that all is unremarkable. From the allergist they often get negative allergy tests, because many mast cell activations do not run through classical IgE antibodies.
The following list is not a diagnosis. It is a mirror in which you can look for patterns. Most MCAS patients have symptoms in at least three of these organ systems.
Symptoms by organ system
- Skin. Flushing, sudden redness in the face and on the décolleté, itching, hives, dermographism, eczema, sensitive skin to fabrics and skincare
- Gut. Abdominal pain, bloating, diarrhoea alternating with constipation, nausea, reflux, food intolerances, pain after meals
- Airways. Stuffy or runny nose without a cold, cough irritation, chest tightness, asthma-like episodes
- Cardiovascular. Palpitations without obvious reason, blood pressure swings, dizziness when standing up, syncope, hot and cold flushes
- Nervous system. Brain fog, concentration difficulty, word-finding problems, migraine, insomnia, anxiety, panic, sensory overload
- Musculoskeletal. Joint pain, muscle pain, post-exertional fatigue, hypermobile joints
- Urogenital. Irritable bladder, bladder pain, painful menstruation, worsening before the period, sexual sensitivity changes
- Constitutional. Fatigue, low resilience, weight loss or gain, feeling cold without reason, night sweats
Many women experience a worsening in the second half of the cycle and in menopause. That is no coincidence. Oestrogen can activate mast cells directly. Many people remember a childhood in which everything was normal, and that at some point something big happened. A surgery, an extended stay abroad, a severe infection, a pregnancy, a trauma. After that the body became different. This tipping point is often the most valuable diagnostic detail.
More symptoms does not mean more illnesses. It often means one deep root that reaches into many organ systems at once.
Section 3The diagnosis that falls through the cracks
Medically, MCAS is officially diagnosed when three criteria are met. Multisystemic, mast-cell-mediated symptoms. An objective rise in a mast cell mediator like tryptase in the blood during a flare. And a response to mast cell directed therapy. The strict variant, called consensus-1, requires a tryptase rise of at least twenty per cent plus two nanograms per millilitre above the personal baseline.
The practical problem with this definition is timing. Mast cells release their content in flares. People sitting at the family doctor are usually not in a flare. Tryptase is only briefly elevated during a flare and quickly drops back down. Those without the luck of timing fall through the cracks. The softer variant, consensus-2, allows clinical signs and other mediators like n-methylhistamine in urine. Under this definition up to seventeen per cent of the population may be affected.
What does this span between two and seventeen per cent tell us? It tells us the question is not only biochemical but cultural. Those who look find much. Those who look away find nothing.
An international review from 2020 showed that the stricter criteria exclude many patients who are clinically clearly affected, and that underdiagnosis is the much larger problem than overdiagnosis. The authors estimated prevalence at up to seventeen per cent of the general population, depending on criteria used.
Afrin LB et al., Diagnosis 2020. DOI
A 2024 review sharpened the picture. Symptom-only diagnosis without a mediator finding is problematic, and at the same time many patients clinically belong to MCAS without a measurable acute tryptase rise. The research field is in movement.
Gulen T, Curr Allergy Asthma Rep 2024. DOI
A diagnosis you cannot fulfil is not automatically a diagnosis you do not have. Sometimes it is just a diagnosis that has not yet found its language.
When stress lights the mast cell directly
When you live in constant alarm, your brain releases a hormone called CRH, short for Corticotropin-Releasing Hormone. It is classically seen as a precursor of cortisol. But CRH also acts directly on mast cells, because they carry a receptor called CRH-R1. A human research study from 2021 showed in humans that CRH stimulates mast cells not only to release but even to multiply. Stress is therefore not only a felt but a cellularly demonstrable mast cell signal.
Add to this the close contact with the nervous system itself. Mast cells sit directly at nerve endings and at microglia, the immune cells of the brain. When they are chronically active, a state arises that research calls neuroinflammation. This silent inflammation explains brain fog, migraine, sensory overload and sleep disturbance much better than any purely psychological framework.
In polyvagal language mast cell calming belongs to the ventral vagus, the social, safe part of your nervous system. Those who live in sympathetic overdrive keep their guards in permanent alarm. This is where breath, vagal exercise and safe attachment become therapy.
A 2021 study showed in human tissue that Corticotropin-Releasing Hormone increases mast cell numbers and stimulates both their degranulation and proliferation. A CRH receptor antagonist blocked the effect. Stress is not only a trigger but a direct biochemical switch.
Yamanaka-Takaichi M et al., Int J Mol Sci 2021. DOI
IgE is not everything. Many pathways are much quieter
Classical allergy runs through immunoglobulin E, or IgE. Someone with a peanut allergy makes IgE antibodies against peanut proteins. These antibodies dock onto mast cells, and at the next peanut contact the cell releases its content. This pathway is well known, well testable, well treatable.
In MCAS, IgE often plays only a small role. Most activations run through other pathways. Through complement fragments, through bacterial lipopolysaccharides, through mycotoxins, through heavy metals, through neuropeptides like substance P, through oestrogen, through adenosine, through touch, heat or cold. This is why classical allergy tests are often unremarkable in MCAS, and this is why many doctors say there is nothing to find, even though the patient feels everything.
In PNI we think of mast cells as the gate where innate and acquired immunity meet. They react quickly like the innate system and learn slowly like the acquired one. Those who keep receiving too many stimuli have a gate that never fully closes again.
Section 4The trigger gallery. What can stand behind it
What matters in MCAS is not the label. What matters is the cause. Those who only suppress the mast cell will see it flare again. Those who ask what is upsetting it get a chance for change. In functional medicine we therefore screen seven to eight main categories of triggers. They usually come in combination, rarely alone.
Chronic stress, unresolved trauma, exhaustion
As described, CRH activates mast cells directly. Those living in chronic strain, be it work, caregiving, difficult relationships, unprocessed trauma, keep their mast cells on alert. Early adversity such as a harsh childhood, frequent separations, traumatic surgery or severe illness shapes the stress system for decades. This is not a question of blame. It is a finding.
Infections that never really cleared
Long COVID has stirred up mast cell research in recent years. A 2021 study showed that the symptom profile of Long COVID patients and classical MCAS patients is virtually identical. More than four out of ten Long COVID sufferers meet mast cell mediated criteria. But Long COVID is only one example. Latent Epstein-Barr virus, chronic Borreliosis, reactivated herpes viruses, Bartonella, Mycoplasma, Candida overgrowth, all can be a quietly burning fire under the mast cells.
An observational study from 2021 compared Post-COVID patients with classical MCAS patients. Symptom profile and severity were practically identical. The research group hypothesised that many Long COVID pictures are a late decompensated or newly triggered mast cell activation.
Weinstock LB et al., Int J Infect Dis 2021. DOI
A 2023 review explains mechanistically how the SARS-CoV-2 spike protein can disturb the blood-brain barrier via mast cells and microglia. About forty-five per cent of COVID sufferers report symptoms months later. Mast cell activation becomes one of the most plausible shared endpoints of many Long COVID pictures.
Theoharides TC, Cells 2023. DOI
Mould and mycotoxins, often from water damage
Those who lived in an apartment with hidden mould sometimes carry the load with them for years. Mycotoxins, the metabolic products of certain moulds like Aspergillus, Stachybotrys or Penicillium, can activate mast cells directly. A very recent study shows that Ochratoxin A can prompt mast cells to release mediators. Add to this growing fatigue, brain fog, breathing problems, frequent infections. In the North American literature the term chronic inflammatory response syndrome or CIRS has emerged. Structural brain changes were found on MRI in water-damage-exposed patients in more than four out of ten people, compared with about one in twenty in a healthy control group. The CIRS label is controversial in conventional medicine. In functional medicine it belongs on the list as soon as the history fits.
A 2014 study by the Shoemaker group showed volumetric brain changes in patients with chronic mould exposure. Gliotic areas appeared in more than forty-five per cent of cases compared with around five per cent of controls. Structural changes were not imagined but visible.
Shoemaker RC et al., Neurotoxicol Teratol 2014. DOI
Heavy metals
Mercury from old amalgam fillings, silver, gold, aluminium from certain cosmetics and adjuvants, cadmium from cigarette smoke and industrial exposure, lead from old water pipes. These metals activate mast cells via oxidative stress and via oxidation of certain sulphur groups in the cells. Anyone carrying a silent heavy metal load for years keeps mast cells in a state of permanent low-grade activation. A 2011 review summarises the data and names mercury, gold and silver explicitly as inducers of both mast cell release and autoimmune patterns.
A 2011 pharmacological review shows that mercury, gold and silver alter immune responses and activate mast cells. Silver triggers release through Reactive Oxygen Species and via oxidation of thiol groups. Such mechanisms explain why heavy metal exposure can act silently over years, without producing an acute poisoning picture.
Suzuki Y et al., Curr Pharm Des 2011. DOI
Parasites and gut dysbiosis
Evolutionarily mast cells are the antibody-bearing main weapon against worms and protozoa. Without them parasites would have wiped out our ancestors. Yet anyone with a chronic, often unnoticed parasitic burden keeps this system permanently active. Add to that the gut itself. When microbes tip, when the mucosa becomes leaky, when more undigested protein fragments cross the wall, mast cells recognise it as a threat. In stool tests we can find traces. Calprotectin, zonulin, pancreatic elastase, beta-defensin, microbial diversity, parasite PCR.
Hypermobility and connective tissue laxity
Maybe you did the splits as a child without warming up. Maybe you sprain your ankle often. Maybe you dislocate your shoulder in your sleep. This overflexibility has a name, the hypermobile Ehlers-Danlos spectrum. It accompanies MCAS and Postural Orthostatic Tachycardia Syndrome POTS remarkably often. The combination is called the HSD-POTS-MCAS triad. In some cohorts eighty-seven per cent of POTS patients met clinical MCAS criteria. With the strict tryptase definition only two per cent did. This span shows how diagnosis is prevented or enabled. The American Gastroenterological Association in 2025 explicitly recognised in a guideline that these patients can benefit from H1 and H2 blockers, mast cell stabilisers and elimination diets.
An analysis from 2025 shows that the prevalence of MCAS in a POTS cohort ranges from two to eighty-seven per cent, depending on the definition used. Patients benefit therapeutically regardless of definition. A clinically oriented diagnosis is therefore more pragmatic than a strictly laboratory-centred approach.
Yao L et al., Front Neurol 2025. DOI
Histamine-rich food and a tired histamine breakdown
Histamine in food is not the problem if your body breaks it down quickly. The most important breakdown enzyme is diamine oxidase or DAO. It sits in the gut mucosa. Those with a damaged mucosa, chronic inflammation, or certain gene variants, break down food histamine more slowly. What clinically looks like its own disease, histamine intolerance, is often a sibling of MCAS. In the next blog post on vivecura.de I go deep into histamine intolerance. Here it should just become clear that both pictures overlap but are not identical. MCAS is the multisystemic activation of the watchman cell. Histamine intolerance is the impaired breakdown of a single messenger at the gut gate. Those who have both have double work to do.
Environmental chemicals and silent loads
Glyphosate, pesticide residues, plasticisers, PFAS, certain preservatives, microplastics, fragrances, electromagnetic fields. Here the scientific data is most uncertain. In functional medicine we nonetheless keep seeing patients whose MCAS improves noticeably after moving to the countryside, switching to organic food, eliminating fragrance products and taking a digital reset. I describe it cautiously. It can play a role. It is not proven in every study, and I promise nothing. But if you have been cleanly evaluated everywhere else and still suffer, these points are worth a look.
Behind MCAS there is almost always a story no one has asked. The story rarely begins today. It often begins ten, twenty, thirty years ago.
Section 5MCAS and histamine intolerance. Siblings, not twins
Because so many people confuse the two, here is a brief and clear distinction. We will go much deeper into histamine intolerance in the next article.
Histamine intolerance is primarily a gastrointestinal phenomenon. Food histamine is not broken down quickly enough, because diamine oxidase in the gut mucosa is genetically slow, or because the mucosa is chronically inflamed, or because certain medications and alcohol inhibit the enzyme. Symptoms often appear after meals with red wine, aged cheese, cured sausage, fermented foods, tomatoes, spinach, chocolate, fish and seafood. Migraine, skin flushing, abdominal pain, diarrhoea, runny nose, palpitations are typical. A low-histamine diet and, if indicated, DAO supplementation with meals often help.
MCAS is the multisystemic activation of the mast cells themselves. They release hundreds of messengers, not only histamine. Triggers are diverse, the course chronic with flares, the diagnosis more complex, the therapy more multimodal. Those with MCAS often also have histamine intolerance. Those with histamine intolerance do not necessarily have MCAS.
Histamine intolerance is the symptomatology of a single messenger that is not broken down. MCAS is the exhaustion of the watchman cell that releases too many messengers at once. Both deserve understanding, but different paths.
Section 6An anthroposophic lens on the mast cell picture
Anthroposophic medicine looks at the human being differently from conventional medicine. It asks not only what the lab shows but also what the inner warmth is doing. Those who suffer chronically from MCAS often have a disturbed warmth organisation. Some patients describe a sense of cold and at the same time hot flushes, a restless oscillation between freezing and burning. In anthroposophic language the inner human seeks his middle and cannot find it.
Mast cells sit in the boundary tissues. In the skin, in the mucous membranes, in the vessel walls. Connective tissue in the anthroposophic image is the organ that carries warmth and gives form. When connective tissue is soft, overstretched and overstimulated, as in the hypermobile triad, a certain structural force is missing. Mast cells react more strongly than they should in an unbraced space. Anthroposophic medicinal plants traditionally used here work on the warmth and structure level. Yarrow warms and orders the middle. Wormwood brings bile and liver into play. Blackthorn strengthens inner substance after exhaustion. Mistletoe modulates the immune system. Bryophyllum calms and grounds sensory stimuli. Choleodoron supports liver and gallbladder, the central detoxification axis for histamine and other mediators.
Please read this section correctly. None of these remedies has large randomised trials in MCAS. They come from a tradition that takes different paths of knowledge. In my practice I often find that they bring complementary warmth to a cold illness. They do not replace serious conventional diagnostics. They can be part of a whole treatment.
MCAS is not only a lab finding that fits or does not fit. MCAS is also an experience at the boundary between inside and outside, where the body can no longer tell friend from foe.
Oestrogen, thyroid, and the inner weather
Mast cells carry oestrogen receptors. Many women therefore experience worsening just before the period, when oestrogen is relatively high and progesterone is low. Pregnancy or menopause can also be when MCAS symptoms first appear or massively increase. Progesterone tends to be more stabilising. Important hormonal levers live here.
The thyroid joins in too. Undiagnosed Hashimoto disease can promote mast cell activation through inflammatory mediators. Cortisol from the adrenal gland acutely brakes mast cells, but in chronic alarm the HPA axis derails, and then the natural brake is missing. Those living long in chronic stress lose their own anti-allergic switch.
In PNI we speak of the interplay between nervous system, immune system, metabolism and hormones. It is not a row of separate organs. It is a net that recognises itself in each part and can together tip back or not.
Section 7Therapeutic paths. What three lenses can offer
The therapy of MCAS is multidimensional. There is no single remedy. There are stages, layers, and a long breath. In my practice I sort therapeutic paths into four categories. Conventional medicine in the narrow sense. Functional and PNI substances. Nutrition and microbiome. Lifestyle and anthroposophic support. An honest note on evidence accompanies each point.
Conventional building blocks
H1 antihistamines. Substances like cetirizine, loratadine, bilastine, fexofenadine or desloratadine block the H1 histamine receptor, which mediates skin redness, itching, sneezing and swelling. They are the first tool and usually well tolerated. If you react strongly with sedation, you can try different preparations. Evidence is good, they are officially recognised.
H2 antihistamines. Substances like famotidine block the H2 histamine receptor, which mainly influences gastric acid and heart rhythm. They help especially with gastrointestinal symptoms and palpitations. Also established.
Mast cell stabilisers. Cromolyn, also known as cromoglicic acid, is a classical option. Taken orally or locally, it acts directly on the mast cell and reduces its tendency to release. Ketotifen acts antihistaminergic and stabilising at once, with somewhat more sedation. Both belong in a doctor's hands.
Low Dose Naltrexone, LDN. Here it becomes exciting and honest. Naltrexone is actually an opioid blocker, approved at higher doses for addiction. In very low doses it appears to act immunomodulatory, mainly on microglia and certain inflammatory pathways. In MCAS, fibromyalgia, chronic fatigue and autoimmune conditions many patients report clear improvements. Honest framing matters. LDN in MCAS is off-label. The evidence consists of smaller studies and especially clinical experience. It is not for everyone and requires medical guidance.
Anti-IgE therapy and biologicals. Omalizumab, an antibody against IgE, has shown good effect in individual studies and case series for severe MCAS. It remains a specialist option. Other biologicals are currently being investigated.
Functional and PNI substances
In functional medicine and PNI we use a range of natural substances that can stabilise mast cells, support histamine breakdown or dampen inflammation. I list them by effect. Evidence for each point varies. Some are supported by many cell studies and some human work. Others are primarily clinical experience.
Quercetin. A flavonoid from onions, apples, capers, parsley. It can stabilise mast cells, inhibits histamine release in cell cultures and in some human studies. It also acts as an antioxidant. Evidence is largely from cell experiments and small clinical work. In functional medicine often a first pillar.
Luteolin. A closely related flavonoid, described by Theoharides as particularly effective in mast cell research. It seems to calm both mast cells and microglia. Mostly preclinical evidence.
Rutin. Another flavonoid, often combined with quercetin. Stabilises blood vessels and can modulate mast cells.
Vitamin C. Histamine is measurably broken down faster in the presence of vitamin C. Those chronically low in vitamin C metabolise histamine more slowly. Vitamin C also acts as an antioxidant and adrenal cofactor. In functional medicine it is often used in infusion.
Vitamin D. Not only a bone vitamin. It modulates the immune system and correlates inversely with allergic activity in observational studies. A level in the lower normal range should be raised in MCAS.
Magnesium. Cofactor in hundreds of enzymes, calms the nervous system, may indirectly stabilise mast cells. Many MCAS patients are low in magnesium, often with calf cramps, restless legs and irritability.
Zinc. Important for immune balance, mucosal regeneration and also DAO activity. Deficiency is common.
Vitamin B6 and copper. Diamine oxidase needs B6 as cofactor and copper as central atom to break down histamine. Subtle shortage here can generate much symptomatology.
Diamine oxidase as a supplement. Given before histamine-rich meals in proven histamine intolerance, it can ease acute symptoms. Effect is in the gut, not systemic. The data base is growing but still in motion.
Bromelain. Enzyme from pineapple, anti-inflammatory, can support mucosal regeneration. Often combined with quercetin.
Curcumin and Boswellia. Plant-based inflammation moderators. Bioavailability matters, so liposomal or phytosomal forms.
Omega-3 fatty acids. From fish or algae oil. Provide the substrate for resolvins, the body's own resolving signals. Often low in MCAS.
Black seed oil, Nigella sativa. Contains thymoquinone, which shows antiallergic and antihistaminergic properties in studies. Widely used clinically in functional medicine with positive experience.
EGCG from green tea. Polyphenol with anti-inflammatory action, interesting in mast cell research.
N-acetyl-cysteine and glutathione. Antioxidant heavyweights, help against oxidative stress that fuels mast cells. Especially relevant in heavy metal load and chronic toxin exposure.
Methylation nutrients. Methylcobalamin, methylfolate, trimethylglycine. Help methylate histamine and thus break it down. Especially relevant with MTHFR gene variants.
Probiotics with histamine-degrading strains. Bifidobacterium infantis, Bifidobacterium longum, Lactobacillus rhamnosus GG, certain Streptococcus strains break down histamine in the gut. Some strains produce histamine. The choice must be careful.
An honest note. Much of what I list here has no large randomised trials specifically for MCAS. The evidence is a mosaic of cell experiments, small human studies and clinical experience. I claim nothing. I offer to test together what could work for you.
A 2018 review summarises that flavonoids like quercetin and luteolin stabilised mast cells in numerous preclinical studies. Human evidence is smaller but consistent with the cellular picture. In functional medicine these substances are therefore often the first gentle pillar.
Theoharides TC et al., 2018. PMID 29282192
Nutrition and microbiome
A low-histamine trial period. For four to six weeks, histamine-rich, histamine-liberating and biogenic-amine-rich foods are reduced. Freshly prepared, freshly bought, quickly eaten. Aged cheese, cured sausage, red wine, beer, fermented products, aged meat, tomatoes, spinach, avocado, sauerkraut, soy sauce, chocolate, strawberries, citrus can be reduced in this phase. This diet is a diagnostic tool, not a life plan. If clear improvement appears after four to six weeks, that is an important hint. Then we expand step by step, individually tolerated.
Mucosal regeneration. L-glutamine, mucilaginous substances like slippery elm and marshmallow, polyphenols, bone broth can nourish the mucosa. Avoiding gluten and industrial plant oils may help in those who are sensitive.
Hydration. Mineral-rich still water, small sips, sufficient but not exaggerated.
Lifestyle and vagal work
Here lie levers no one takes for you and no one can prescribe for you.
Breath. Long exhalation, five seconds in, seven seconds out. Humming. Gargling. Singing. All activate the ventral vagus.
Sunlight and oxygen. Twenty minutes of morning natural light without sunglasses. This stabilises circadian rhythm and with it cortisol and histamine.
Movement within your capacity. Walks, yoga, Qigong, gentle strength training. For some patients intense movement initially triggers, because effort itself can activate mast cells. Patience is key.
Heat with caution. Sauna helps some and triggers others. Infrared is often better tolerated. Yarrow oil liver compresses are an anthroposophic measure with a calming effect on the middle.
Sleep. Seven to nine hours, dark room, clear bedtime, no screens in the last minutes. In sleep microglia regulate, and there the mast cell system calms too.
Stress and trauma work. Here lies the decisive lever for many. Those who had to carry too much too early in childhood trained their mast cells literally young. Polyvagal exercises, Somatic Experiencing, EMDR, IFS, mindfulness-based therapy can release deep traces.
Anthroposophic support
Yarrow, Choleodoron, Bryophyllum, mistletoe, Hepatodoron for the liver, Cardiodoron for the middle. These remedies come from a tradition I respect and which has its place in my practice. I promise nothing. I offer them as an additional layer in a treatment plan that speaks several languages.
Therapy in MCAS is never a single remedy. It is a composition of several instruments that together learn to play a quieter piece.
Section 8Differentiate, do not oversimplify
A good article must also say where MCAS does not fit. Not every complex symptom mix is MCAS. The following diagnoses must be considered, some need to be ruled out or confirmed first.
Systemic mastocytosis. A rare clonal mast cell disease with elevated baseline tryptase. Needs haematological evaluation.
Hereditary alpha-tryptasemia. A genetic variant with raised tryptase, present in a small percentage of the population, which can amplify MCAS-like symptoms.
Classical IgE allergies. They should be tested, especially with clear triggers.
Carcinoid syndrome. A rare neuroendocrine tumour with flushing and diarrhoea. Must be ruled out in atypical courses.
Hyperthyroidism. Can cause palpitations, sweating and irritability. Belongs in the basic workup.
Phaeochromocytoma. Very rare but important to rule out in attack-like hypertension with sweating.
Functional dyspepsia and irritable bowel syndrome. Overlap with MCAS. Some of these patients are actually MCAS patients, some are not.
Psychiatric conditions. Anxiety and panic disorders can present biologically similar. They can coexist or be a consequence of unrecognised MCAS. They deserve their own language and their own therapy.
A diagnosis is not a sign over your door. It is a map for a specific region. Some regions overlap. A good doctor knows in which one you are right now, and which others you might still travel through.
Section 9What you can do now
You have read this far. You are probably tired, probably hopeful, probably both. Here is a concrete guide to what you can set in motion yourself before coming to a specialist consultation. These steps do not replace medical advice. They give us a better starting point.
Six steps you can take now
Each of these steps gathers a piece of the puzzle. Together they paint a picture that most fifteen-minute family doctor visits cannot draw.
- Keep a symptom diary for two weeks. Note daily sleep, stress, menstrual phase, meals, environmental exposure, symptoms. You will see patterns that help the practice immediately.
- Make an honest inventory of your trigger history. When did it start? What was going on then? Were there water damages in the home? Amalgam fillings? Severe infection? COVID? A difficult life phase? A major surgery? Gather a timeline and concrete events.
- For four weeks reduce the most obvious histamine triggers. Red wine, sparkling wine, aged cheese, cured sausage, soy sauce, fermented foods, tomatoes, spinach, chocolate, strawberries. See how your symptoms change. This is diagnostically more valuable than any expensive test.
- Breathe consciously every day. Three times seven minutes. Four seconds in, seven seconds out. You are training your ventral vagus, the only built-in brake of the mast cell.
- Bring the following lab work to the practice. Blood tryptase, plasma histamine, n-methylhistamine in 24-hour urine, serum diamine oxidase, eosinophil cationic protein, total and specific IgE if history fits. Full blood count, differential, ferritin, vitamin D, vitamin B12, folate, magnesium, zinc, copper, selenium. TSH, free T3, free T4, TPO and TG antibodies. Calprotectin and zonulin in stool, parasite PCR in stool. If mould suspected, urine mycotoxins and ideally a professional home inspection. If heavy metal suspected, whole-blood mineral panel with mercury, lead, cadmium. With suspected chronic infections, Borrelia serology, EBV reactivation markers, and if indicated Bartonella and Mycoplasma. This list looks long. It is not all at once. It shows me what is sensible when we look together into your story.
- Until then treat yourself not as a patient but as a researcher. You are gathering data about yourself. You observe. You hold off hard conclusions until the picture stands together. That is the only attitude that works long term with MCAS.
Section 10And now you know why
The woman this text began with today has a picture in which her symptoms fit. We worked in several steps. A mould remediation of the old apartment. A gentle heavy metal detox over several months, with mercury challenge test, glutathione, binders, and parallel micronutrient rebuilding. A treatment of the still active Long COVID component with low-dose mast cell stabilisers, vitamin C infusions, quercetin, black seed oil, and a careful LDN phase with clear medical disclosure of the off-label status. A stabilisation of the hypermobile joints with targeted connective tissue training. Trauma-sensitive support with the therapist she chose herself. A low-histamine trial phase, then slow expansion. Hepatodoron and Choleodoron for the liver axis, yarrow oil liver compresses as a weekly ritual. Not all at once. In an order her body could follow.
Today, after about twelve months, she has not lost all symptoms. That would be a healing promise I do not make. But she is clearly clearer in her head. Her skin has calmed, her gut too. She can tolerate small amounts of wine again. She can travel. She sleeps. She wakes in the morning without her heart already racing. A single course is no guarantee for the next. Yet it shows that there is a path when someone asks the right question.
You are not too complicated. You are not too sensitive. You are not imagining this. Your body is doing something that has its place in medical literature, but does not receive enough time in most consultations. You do not need someone who tells you it is all in your head. You need someone who asks the right questions, listens well, and builds a plan that fits your story.
True freedom is not being symptom-free. True freedom is trusting your body again, that it has a reason to react the way it does. And finding that reason together.
In the next article on vivecura.de I look deeply at histamine intolerance. Those who recognise both can orient themselves better. Those who confuse them fight on the wrong front. Until then, breathe. You are not alone. This diagnosis is real, and it is treatable.
Sources
- Afrin LB et al. Diagnosis of mast cell activation syndrome. A global consensus-2. Diagnosis (Berl) 2020. doi.org/10.1515/dx-2020-0005
- Gulen T. Mast Cell Activation Syndromes. Diagnostic Challenges and 2024 Update. Curr Allergy Asthma Rep 2024. doi.org/10.1007/s11882-024-01126-0
- Weinstock LB et al. Mast cell activation symptoms are prevalent in Long-COVID. Int J Infect Dis 2021. doi.org/10.1016/j.ijid.2021.09.043
- Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Cells 2023. doi.org/10.3390/cells12050688
- Yamanaka-Takaichi M et al. Stress and Nasal Allergy. CRH stimulates mast cell degranulation. Int J Mol Sci 2021. doi.org/10.3390/ijms22052773
- Hagiwara SI et al. Stress-induced CRF in colonic mast cells. PLoS One 2018. doi.org/10.1371/journal.pone.0203704
- Suzuki Y et al. Heavy metals and mast cell activation. Curr Pharm Des 2011. doi.org/10.2174/138161211798357917
- Yoshimaru T et al. Silver activates mast cells through reactive oxygen species. Free Radic Biol Med 2006. doi.org/10.1016/j.freeradbiomed.2006.01.023
- Shoemaker RC et al. Structural brain abnormalities in patients exposed to water-damaged buildings. Neurotoxicol Teratol 2014. doi.org/10.1016/j.ntt.2014.06.004
- Dooley M et al. Chronic Inflammatory Response Syndrome. A literature review. Ann Med Surg 2024. doi.org/10.1097/MS9.0000000000002718
- Yao L et al. POTS and MCAS. A prospective cohort. Front Neurol 2025. doi.org/10.3389/fneur.2025.1513199
- Aziz Q et al. AGA Clinical Practice Update on Joint Hypermobility Spectrum Disorders. Clin Gastroenterol Hepatol 2025. doi.org/10.1016/j.cgh.2025.02.015
- Schnedl WJ, Enko D. Histamine Intolerance Originates in the Gut. Nutrients 2021. doi.org/10.3390/nu13041262
- Mukai K et al. Mast cells as sources of cytokines, chemokines, and growth factors. Semin Immunopathol 2016. doi.org/10.1007/s00281-016-0565-1
- Theoharides TC et al. Recent advances in understanding of mast cell activation. 2018. PMID 29282192
- Tsilioni I et al. Ochratoxin A and human mast cells. Cells 2025. PMID 39859348
This article serves educational purposes and does not replace personal medical advice, diagnosis or therapy. Changes to medications or supplements should only be made in consultation with a physician. Off-label uses such as LDN, functional substances without large randomised trials, and anthroposophic support are explicitly marked as such. Written by Shukri Jarmoukli, ViveCura private practice, Berlin.